Silva Francisco
SEC CIK 1527241 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BRTX | BioRestorative Therapies, Inc. | VP of Research, Development, Dir, 10% | 171.4K | $129.8K | $13.4K | 18 | 2021-11-16 | 2025-10-06 |
Most active insiders at BRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | — | — |
| 2 | Silva Francisco | VP of Research, Development, Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-20 | 2025-10-06 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | A - Grant | $1.60 | +11.7K | 171.4K | +7% | +$18.8K |
| M | 2024-04-10 | 2024-04-08+ | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $1.23 | +8,308 | 155.8K | +6% | +$10.2K |
| 2024-03-20 | 2024-03-18 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | F - Tax | $1.39 | -17.2K | 147.5K | -10% | -$23.9K | |
| 2023-08-31 | 2023-08-31 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir, 10% | P - Purchase | $2.22 | +4,954 | 164.6K | +3% | +$11.0K | |
| 2023-04-04 | 2023-03-31 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir, 10% | P - Purchase | $3.56 | +747 | 159.7K | +0.5% | +$2,659 | |
| 2023-03-22 | 2023-03-20 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir, 10% | F - Tax | $2.92 | -6,729 | 158.9K | -4% | -$19.6K | |
| 2023-02-28 | 2023-02-18 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir, 10% | F - Tax | $2.99 | -374 | 165.7K | -0.2% | -$1,118 | |
| 2022-11-21 | 2022-11-21 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $2.62 | +943 | 166.0K | +0.6% | +$2,471 | |
| 2022-10-12 | 2022-10-11 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $3.69 | +806 | 164.4K | +0.5% | +$2,974 | |
| 2022-10-12 | 2022-10-12 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $3.39 | +725 | 165.1K | +0.4% | +$2,458 | |
| 2022-09-09 | 2022-08-26 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | S - Sale | $3.39 | -3,958 | 158.2K | -2% | -$13.4K | |
| I | 2022-09-09 | 2022-08-29 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $3.32 | +307 | 12.1K | +3% | +$1,019 |
| M | 2022-09-09 | 2022-08-26+ | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $3.28 | +5,416 | 160.8K | +3% | +$17.7K |
| 2022-06-15 | 2022-06-14 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | A - Grant | $3.78 | +263 | 162.1K | +0.2% | +$994.14 | |
| 2022-06-08 | 2022-06-07 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | A - Grant | $4.65 | +565 | 161.9K | +0.4% | +$2,627 | |
| 2022-03-22 | 2022-03-18 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | A - Grant | — | +12.4K | 161.3K | +8% | — | |
| I | 2021-11-22 | 2021-11-19 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $6.66 | +4,000 | 11.8K | +51% | +$26.6K |
| MI | 2021-11-16 | 2021-11-16 | BRTX | BioRestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $6.73 | +7,826 | 3,829 | New | +$52.7K |
Purchase Sale Sale after option exercise All abbreviations